IndraLab

Statements

Cisplatin inhibits MAP3K7. 2 / 2

| 2

reach

"Depletion of PARVB promotes cisplatin-induced TAK1 degradation, inhibits TAK1 downstream signaling, and ultimately alleviates cisplatin-induced tubular cell damage."

39235496

➶

reach

"Then, we applied a TAK1 overexpression vector to reverse authenticate the effect of TAK1 on cell autophagy using renal tubular epithelial cells treated with cisplatin invitro."

29504713

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Cisplatin inhibits MAP3K7. 2 / 2

INDRA sources:

Databases

Reading